Most Patients Using IVF-PGS Do Not Want to Select Gender of Child
Nov 01, 2017
Origin: ASRM Press Release
HIGHLIGHTS FROM THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE’S 2017 SCIENTIFIC CONGRESS & EXPO
Note: Press room open Sun. October 29, 2pm-5pm CDT; Mon. October 30-Wed. November 1, 8:00am-5:30pm CDT. 210-582-7029
San Antonio TX- Research presented today at the American Society for Reproductive Medicine’s Scientific Congress showed that the vast majority of patients utilizing genetic screening technologies opt not to choose the gender of their child, despite the ease of obtaining the information to do so.
Researchers from Reproductive Medical Associates of New York examined 5 years’ worth of decisions made by patients undergoing various forms of Pre-Implantation Genetic Screening (PGS). Only 18% of the nearly 500 couples in the study used gender as criteria for choosing which of their embryos to transfer. 82% indicated no preference. Of the patients who did express a gender preference, over 2/3, 68% chose female embryos.
“There are a lot of assumptions made about how patients will use technologies like PGS. This study shows that many of those assumptions, and the fears they generate, may be unfounded,” stated Kevin Doody, MD, President of the Society for Assisted Reproductive Technology.
P-450 I. Levin et al,” HOW OFTEN DO PATIENTS UNDERGOING IVF WITH PREIMPLANTATION GENETIC SCREENING HAVE AN EMBRYO SEX PREFERENCE?”
ASRM is a multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated health care providers. The Society is committed to facilitating and sponsoring educational activities for the lay public and continuing medical education activities for professionals who are engaged in the practice of and research in reproductive medicine. www.asrm.org